Showing results (221-230 of 242) with videos related to
Sort By:
Pageof 25
Breast Cancer Research and Treatment|March 27, 2021
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center studyDaniel Reinhorn, Iryna Kuchuk, Tzippy Shochat, et al.The Journal of Biological Chemistry|November 13, 2012
Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat)Klilah Hershko, Vijaya L Simhadri, Adam Blaisdell, et al.BMC Bioinformatics|September 6, 2024
Mouse embryo CoCoPUTs: novel murine transcriptomic-weighted usage website featuring multiple strains, tissues, and stagesSarah E Fumagalli, Sean Smith, Tigran Ghazanchyan, et al.JCO Precision Oncology|November 5, 2024
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 TrialGopa Iyer, Catherine M Tangen, Michal Sarfaty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint BlockadeMichal Sarfaty, Mahdi Golkaram, Samuel A Funt, et al.Journal of Robotic Surgery|September 9, 2024
Robotic colorectal resections are associated with less postoperative pain, decreased opioid use, and earlier return to work as compared to the laparoscopic approachYael Berger, Nazanin Khajoueinejad, Sayed Imtiaz, et al.European Journal of Gastroenterology & Hepatology|March 1, 1996
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)C Florent, A Cortot, P Quandale, et al.Frontiers in Oncology|June 9, 2023
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysisKeren Rouvinov, Eran Levanon, Avivit Peer, et al.Cancer Medicine|December 31, 2020
A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tractMichal Sarfaty, Karissa Whiting, Min Yuen Teo, et al.Nature Medicine|September 17, 2013
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia AGouri Shankar Pandey, Chen Yanover, Lisa M Miller-Jenkins, et al.Pageof 25